Joey. You couldn't be more correct in your estimation of this company's current market cap, however, if management can pull a rabbit out of their hat with this cannabinol trial, they might get enough interest to fund getting ampa drugs back in trials. Positive results from those trials would provide a s.p. differential from current levels that would far exceed chump change.
News 
Market Data 
Discover 
